The never-ending problem: Sample size matters

Saved in:
Bibliographic Details
Published inEuropean neuropsychopharmacology Vol. 79; pp. 17 - 18
Main Authors De Prisco, Michele, Vieta, Eduard
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
Author De Prisco, Michele
Vieta, Eduard
Author_xml – sequence: 1
  givenname: Michele
  orcidid: 0000-0002-2032-1181
  surname: De Prisco
  fullname: De Prisco, Michele
  email: mdeprisco@clinic.cat
  organization: Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Institut de Neurociencies, Universitat de Barcelona (UB), c. Casanova, 143, Barcelona, 08036, Spain
– sequence: 2
  givenname: Eduard
  surname: Vieta
  fullname: Vieta, Eduard
  organization: Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Institut de Neurociencies, Universitat de Barcelona (UB), c. Casanova, 143, Barcelona, 08036, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38056029$$D View this record in MEDLINE/PubMed
BookMark eNqNkE1LAzEQhoNU7If-Bd2jl12TbLvZCCKl-AUFD1bwFrLZiabuZmuyLdRfb0qrh17sJYGZ931n5umjjm0sIHRBcEIwya7mCSxdKIUnoZimoZpgTI9Qj-QsjVme0Q7qYU6HMWfsrYv63s8xJqM05Seom-Z4lGHKeyiefUBkYQUuBlsa-x4tXFNUUF9HL7JeVBB58w1RLdsWnD9Fx1pWHs52_wC93t_NJo_x9PnhaTKexmpIWRtryPRQw2YKIYxlBSGKYZxBSUtZsLwYap0RmedMZoyPQBHJdJmOgqXAnOl0gC63uWGZryX4VtTGK6gqaaFZekFzzlNGMMdBer6TLosaSrFwppZuLX5PDIKbrUC5xnsHWijTytY0tnXSVIJgsUEq5uIPqdgg3TQC0uBne_7fEf87x1snBFQrA054ZcAqKI0D1YqyMQdk3O5lqMpYo2T1CeuDEn4AkPirRA
CitedBy_id crossref_primary_10_1016_j_euroneuro_2024_03_006
crossref_primary_10_1016_j_jad_2024_10_002
crossref_primary_10_62401_2531_4122_2024_43
crossref_primary_10_1016_j_beth_2025_01_001
crossref_primary_10_1080_10503307_2025_2465432
crossref_primary_10_1016_j_euroneuro_2024_02_007
crossref_primary_10_1016_j_euroneuro_2024_07_009
crossref_primary_10_1016_j_euroneuro_2025_02_009
crossref_primary_10_1016_j_neubiorev_2025_106081
crossref_primary_10_1016_j_euroneuro_2024_07_004
crossref_primary_10_1016_j_euroneuro_2024_12_006
crossref_primary_10_1016_j_euroneuro_2024_12_002
crossref_primary_10_1016_j_euroneuro_2024_12_001
crossref_primary_10_1016_j_euroneuro_2024_10_012
crossref_primary_10_3390_jcm13133942
crossref_primary_10_1111_bdi_70019
crossref_primary_10_1016_j_psychres_2024_116083
crossref_primary_10_1016_j_neubiorev_2024_105913
crossref_primary_10_1016_j_psiq_2024_100494
crossref_primary_10_1038_s44184_024_00090_x
crossref_primary_10_1016_j_euroneuro_2024_02_011
crossref_primary_10_1016_j_psychres_2025_116422
crossref_primary_10_1016_j_euroneuro_2024_07_013
crossref_primary_10_1016_j_jad_2024_08_140
crossref_primary_10_3390_jcm13174997
crossref_primary_10_1016_j_euroneuro_2024_04_017
crossref_primary_10_1017_S0033291724002149
crossref_primary_10_1016_j_euroneuro_2024_04_014
crossref_primary_10_1016_j_euroneuro_2024_04_015
crossref_primary_10_1111_acps_13733
crossref_primary_10_1192_j_eurpsy_2024_1793
crossref_primary_10_1016_j_sjpmh_2024_07_003
crossref_primary_10_1016_j_euroneuro_2024_07_015
crossref_primary_10_1016_j_euroneuro_2025_01_003
crossref_primary_10_3389_fpsyt_2024_1435199
crossref_primary_10_1002_wps_21219
Cites_doi 10.1016/j.nsa.2023.101129
10.1001/jamapsychiatry.2021.3990
10.1016/j.euroneuro.2023.04.019
10.1016/j.euroneuro.2023.04.014
10.4300/JGME-D-12-00156.1
10.1038/s41591-021-01480-w
10.1016/j.euroneuro.2022.08.001
10.3352/jeehp.2021.18.17
10.1016/j.euroneuro.2022.02.005
10.1038/s41588-021-00857-4
ContentType Journal Article
Copyright 2023 Elsevier B.V. and ECNP
Copyright_xml – notice: 2023 Elsevier B.V. and ECNP
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.euroneuro.2023.10.002
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-7862
EndPage 18
ExternalDocumentID 38056029
10_1016_j_euroneuro_2023_10_002
S0924977X23006983
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABIVO
ABJNI
ABMAC
ABMZM
ABOYX
ABWVN
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HMQ
HMT
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M2V
M34
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OGGZJ
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SPT
SSB
SSH
SSN
SSP
SSY
SSZ
T5K
UNMZH
WUQ
XPP
Z5R
~G-
AACTN
AADPK
AAIAV
AATCM
ABLVK
ABYKQ
AFCTW
AFKWA
AFYLN
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
NPM
7X8
ID FETCH-LOGICAL-c427t-fe6f4fe380511776b11c7006ed2dab78b4ff61a887a6795ec1a7fd35fe3b097f3
IEDL.DBID .~1
ISSN 0924-977X
1873-7862
IngestDate Fri Jul 11 07:24:41 EDT 2025
Wed Feb 19 02:05:15 EST 2025
Tue Jul 01 02:20:08 EDT 2025
Thu Apr 24 23:10:24 EDT 2025
Sat Feb 17 16:11:25 EST 2024
Tue Aug 26 16:38:31 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Drop-out
Underpowered
Sample size
Methodology
Statistical power
Attrition
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c427t-fe6f4fe380511776b11c7006ed2dab78b4ff61a887a6795ec1a7fd35fe3b097f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2032-1181
PMID 38056029
PQID 2899371090
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_2899371090
pubmed_primary_38056029
crossref_citationtrail_10_1016_j_euroneuro_2023_10_002
crossref_primary_10_1016_j_euroneuro_2023_10_002
elsevier_sciencedirect_doi_10_1016_j_euroneuro_2023_10_002
elsevier_clinicalkey_doi_10_1016_j_euroneuro_2023_10_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2024
2024-02-00
2024-Feb
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: February 2024
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle European neuropsychopharmacology
PublicationTitleAlternate Eur Neuropsychopharmacol
PublicationYear 2024
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Sullivan, Feinn (bib0009) 2012; 4
Taipale, Schneider-Thoma, Pinzón-Espinosa, Radua, Efthimiou, Vinkers, Mittendorfer-Rutz, Cardoner, Pintor, Tanskanen (bib0010) 2022; 79
Mullins, Forstner, O'Connell, Coombes, Coleman, Qiao, Als, Bigdeli, Børte, Bryois (bib0005) 2021; 53
Nikolič, Viktorin, Zach, Tylš, Dudysová, Janků, Kopřivová, Kuchař, Brunovský, Horáček (bib0006) 2023; 74
Scangos, Khambhati, Daly, Makhoul, Sugrue, Zamanian, Liu, Rao, Sellers, Dawes (bib0008) 2021; 27
Bjertrup, Væver, Miskowiak (bib0001) 2023; 73
Kessing, Faurholt-Jepsen (bib0004) 2022; 58
Olugemo, Bugarski-Kirola, Dawson, DiCesare, Stevanović, Samardzic, Chatzittofis, Moore, Verster, Bhering (bib0007) 2023; 2
Fusar-Poli, Manchia, Koutsouleris, Leslie, Woopen, Calkins, Dunn, Le Tourneau, Mannikko, Mollema (bib0002) 2022; 63
Kang (bib0003) 2021; 18
Kang (10.1016/j.euroneuro.2023.10.002_bib0003) 2021; 18
Sullivan (10.1016/j.euroneuro.2023.10.002_bib0009) 2012; 4
Taipale (10.1016/j.euroneuro.2023.10.002_bib0010) 2022; 79
Kessing (10.1016/j.euroneuro.2023.10.002_bib0004) 2022; 58
Nikolič (10.1016/j.euroneuro.2023.10.002_bib0006) 2023; 74
Olugemo (10.1016/j.euroneuro.2023.10.002_bib0007) 2023; 2
Fusar-Poli (10.1016/j.euroneuro.2023.10.002_bib0002) 2022; 63
Bjertrup (10.1016/j.euroneuro.2023.10.002_bib0001) 2023; 73
Mullins (10.1016/j.euroneuro.2023.10.002_bib0005) 2021; 53
Scangos (10.1016/j.euroneuro.2023.10.002_bib0008) 2021; 27
References_xml – volume: 58
  start-page: 39
  year: 2022
  end-page: 41
  ident: bib0004
  article-title: Mood instability-a new outcome measure in randomised trials of bipolar disorder?
  publication-title: Eur. Neuropsychopharmacol.
– volume: 73
  start-page: 36
  year: 2023
  end-page: 47
  ident: bib0001
  article-title: Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women
  publication-title: Eur. Neuropsychopharmacol.
– volume: 63
  start-page: 17
  year: 2022
  end-page: 34
  ident: bib0002
  article-title: Ethical considerations for precision psychiatry: a roadmap for research and clinical practice
  publication-title: Eur. Neuropsychopharmacol.
– volume: 18
  start-page: 17
  year: 2021
  ident: bib0003
  article-title: Sample size determination and power analysis using the G* power software
  publication-title: J. Educ. Eval. Health Prof.
– volume: 74
  start-page: 78
  year: 2023
  end-page: 88
  ident: bib0006
  article-title: Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis
  publication-title: Eur. Neuropsychopharmacol.
– volume: 4
  start-page: 279
  year: 2012
  end-page: 282
  ident: bib0009
  article-title: Using effect size—Or why the P value is not enough
  publication-title: J. Grad. Med. Educ.
– volume: 27
  start-page: 1696
  year: 2021
  end-page: 1700
  ident: bib0008
  article-title: Closed-loop neuromodulation in an individual with treatment-resistant depression
  publication-title: Nat. Med.
– volume: 2
  year: 2023
  ident: bib0007
  article-title: Conducting CNS trials during a public health emergency–lessons learned from the COVID-19 pandemic: a joint ISCTM/ECNP working group consensus paper
  publication-title: Neurosci. Appl.
– volume: 79
  start-page: 210
  year: 2022
  end-page: 218
  ident: bib0010
  article-title: Representation and outcomes of individuals with schizophrenia seen in everyday practice who are ineligible for randomized clinical trials
  publication-title: JAMA Psychiatry
– volume: 53
  start-page: 817
  year: 2021
  end-page: 829
  ident: bib0005
  article-title: Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
  publication-title: Nat. Genet.
– volume: 2
  year: 2023
  ident: 10.1016/j.euroneuro.2023.10.002_bib0007
  article-title: Conducting CNS trials during a public health emergency–lessons learned from the COVID-19 pandemic: a joint ISCTM/ECNP working group consensus paper
  publication-title: Neurosci. Appl.
  doi: 10.1016/j.nsa.2023.101129
– volume: 79
  start-page: 210
  year: 2022
  ident: 10.1016/j.euroneuro.2023.10.002_bib0010
  article-title: Representation and outcomes of individuals with schizophrenia seen in everyday practice who are ineligible for randomized clinical trials
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2021.3990
– volume: 74
  start-page: 78
  year: 2023
  ident: 10.1016/j.euroneuro.2023.10.002_bib0006
  article-title: Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2023.04.019
– volume: 73
  start-page: 36
  year: 2023
  ident: 10.1016/j.euroneuro.2023.10.002_bib0001
  article-title: Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2023.04.014
– volume: 4
  start-page: 279
  year: 2012
  ident: 10.1016/j.euroneuro.2023.10.002_bib0009
  article-title: Using effect size—Or why the P value is not enough
  publication-title: J. Grad. Med. Educ.
  doi: 10.4300/JGME-D-12-00156.1
– volume: 27
  start-page: 1696
  year: 2021
  ident: 10.1016/j.euroneuro.2023.10.002_bib0008
  article-title: Closed-loop neuromodulation in an individual with treatment-resistant depression
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01480-w
– volume: 63
  start-page: 17
  year: 2022
  ident: 10.1016/j.euroneuro.2023.10.002_bib0002
  article-title: Ethical considerations for precision psychiatry: a roadmap for research and clinical practice
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2022.08.001
– volume: 18
  start-page: 17
  year: 2021
  ident: 10.1016/j.euroneuro.2023.10.002_bib0003
  article-title: Sample size determination and power analysis using the G* power software
  publication-title: J. Educ. Eval. Health Prof.
  doi: 10.3352/jeehp.2021.18.17
– volume: 58
  start-page: 39
  year: 2022
  ident: 10.1016/j.euroneuro.2023.10.002_bib0004
  article-title: Mood instability-a new outcome measure in randomised trials of bipolar disorder?
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2022.02.005
– volume: 53
  start-page: 817
  year: 2021
  ident: 10.1016/j.euroneuro.2023.10.002_bib0005
  article-title: Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-021-00857-4
SSID ssj0015339
Score 2.5765347
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 17
SubjectTerms Attrition
Drop-out
Methodology
Sample size
Statistical power
Underpowered
Title The never-ending problem: Sample size matters
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0924977X23006983
https://dx.doi.org/10.1016/j.euroneuro.2023.10.002
https://www.ncbi.nlm.nih.gov/pubmed/38056029
https://www.proquest.com/docview/2899371090
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JasMwEBUhvfRSujfdUKH0FCWWrUhWbiG0pFsIXSA340WClDYNTXJID_32zngrOZQUejK2PNh-Gj2N8MwTIedAi9yI2GVcKMuEkYZpK31mXEeHNsE5DQuF7_uy9yxuhq1hhXSLWhhMq8y5P-P0lK3zK80czeZkNGo-Orh0UGoIQbQjtY-Kn0Io9PLGV5nmgeFMprfnCoZ3L-V4of5FqhvZwF3EG2mal_vbDPVbBJrORFebZCMPIWkne8stUjHjbXIxyDSoF3X69FNSNa3TCzr4Uade7BAGzXRswIOZSStaaL6nTJs-higVTKejT0PfMt3NXfJ8dfnU7bF8zwQWC1fNmDXSCms8HwYbV0pGnMcK8DGJm4SR8iNhreQhUEsolW6ZmIfKJl4LTCJHK-vtkeoYMDkg1OhE-QaI1HesiLTUURImkdvyNE84RHk1IgucgjgXFMd9LV6DInPsJSgBDhBgbACAa8QpDSeZpsZqE7_oiKAoGQWSC4D3V5u2S9Mlz_qb8VnR6wGMO_yZEo7N-3wa4ELVw0RWp0b2M3coPwbRl46rD__z6COyDmciyxA_JtXZx9ycQAA0i05TDz8la53uw90Aj9e3vf43HJQH8w
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LaxsxEB5c99BeStOn2zRVoeQU2atdWVrlVkKM29rGEAd8E_uQwCVxQ-0c3EN_e2b2ZXwwDvS62mF3P40-jdiZbwC-Ii0KJ7OQC6k9l045bryKuQsDk_ic9jQqFB5P1PBa_pj35y24qGthKK2y4v6S0wu2rq70KjR7d4tF7yqgo4PWcwyiA2Xi6Ak8lbh8qY1B91-T50HxTCm4F0pOt-8keZEARiEc2aU24t0izyvct0XtC0GLrWjwEl5UMST7Vr7mEbTc8hWcTksR6s0Zm21rqlZn7JRNt_LUm9fAcZgtHbowd0VJC6uaypyzq4S0gtlq8dex21J48w1cDy5nF0NeNU3gmQz1mnunvPQuinG1Ca1VKkSmESCXh3mS6jiV3iuRILckSpu-y0SifR710SQNjPbRW2gvEZP3wJzJdeyQSePAy9Qok-ZJnob9yIhcYJjXAVXjZLNKUZwaW9zYOnXsl20AtgQwDSDAHQgaw7tSVOOwSVxPhK1rRpHlLBL_YdPzxnTHtR5n_KWedYsLj_6mJEv3-35l6aQaUSZr0IF3pTs0H0PoqyA0H_7n0Z_h2XA2HtnR98nPj_AcR2SZLn4M7fWfe_cJo6F1elJ4-wPLGQfs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+never-ending+problem%3A+Sample+size+matters&rft.jtitle=European+neuropsychopharmacology&rft.au=De+Prisco%2C+Michele&rft.au=Vieta%2C+Eduard&rft.date=2024-02-01&rft.issn=1873-7862&rft.eissn=1873-7862&rft.volume=79&rft.spage=17&rft_id=info:doi/10.1016%2Fj.euroneuro.2023.10.002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0924-977X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0924-977X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0924-977X&client=summon